FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064152041> ?p ?o ?g. }

• W2064152041 endingPage "977" @default.
• W2064152041 startingPage "970" @default.
• W2064152041 abstract "Effective pharmacological strategies employed in allogeneic hematopoietic cell transplantation should prevent serious chronic graft-versus-host disease and facilitate donor-recipient immune tolerance. Based on demonstrated pro-tolerogenic activity, sirolimus (rapamycin) is an agent with promise to achieve these goals. In a long-term follow-up analysis of a randomized phase II trial comparing sirolimus/tacrolimus versus methotrexate/tacrolimus for graft-versus-host disease prevention in matched sibling or unrelated donor transplant, we examined the impact of prolonged sirolimus administration (≥ 1 year post-transplant). Median follow-up time for surviving patients at time of this analysis was 41 months (range 27-60) for sirolimus/tacrolimus and 49 months (range 29-63) for methotrexate/tacrolimus. Sirolimus/tacrolimus patients had significantly lower National Institutes of Health Consensus moderate-severe chronic graft-versus-host disease (34% vs. 65%; P=0.004) and late acute graft-versus-host disease (20% vs. 43%; P=0.04). While sirolimus/tacrolimus patients had lower prednisone exposure and earlier discontinuation of tacrolimus (median time to tacrolimus discontinuation 368 days vs. 821 days; P=0.002), there was no significant difference in complete immune suppression discontinuation (60-month estimate: 43% vs. 31%; P=0.78). Prolonged sirolimus administration represents a viable approach to mitigate risk for moderate-severe chronic and late acute graft-versus-host disease. Further study of determinants of successful immune suppression discontinuation is needed." @default.
• W2064152041 created "2016-06-24" @default.
• W2064152041 creator A5000571638 @default.
• W2064152041 creator A5004386819 @default.
• W2064152041 creator A5008162182 @default.
• W2064152041 creator A5009314752 @default.
• W2064152041 creator A5012866839 @default.
• W2064152041 creator A5017327825 @default.
• W2064152041 creator A5021394406 @default.
• W2064152041 creator A5035905546 @default.
• W2064152041 creator A5037882458 @default.
• W2064152041 creator A5045667573 @default.
• W2064152041 creator A5060783496 @default.
• W2064152041 creator A5062691289 @default.
• W2064152041 creator A5068862906 @default.
• W2064152041 creator A5083349008 @default.
• W2064152041 creator A5083687455 @default.
• W2064152041 creator A5087799564 @default.
• W2064152041 date "2015-04-03" @default.
• W2064152041 modified "2023-09-28" @default.
• W2064152041 title "Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease" @default.
• W2064152041 cites W1491993932 @default.
• W2064152041 cites W1499473785 @default.
• W2064152041 cites W1616716935 @default.
• W2064152041 cites W1918052238 @default.
• W2064152041 cites W1937035308 @default.
• W2064152041 cites W1944331591 @default.
• W2064152041 cites W1966429220 @default.
• W2064152041 cites W1970070684 @default.
• W2064152041 cites W1975141436 @default.
• W2064152041 cites W1977168925 @default.
• W2064152041 cites W1977298956 @default.
• W2064152041 cites W1979522386 @default.
• W2064152041 cites W1993797289 @default.
• W2064152041 cites W1994566301 @default.
• W2064152041 cites W1996893745 @default.
• W2064152041 cites W2001895625 @default.
• W2064152041 cites W2005604237 @default.
• W2064152041 cites W2008686731 @default.
• W2064152041 cites W2010965954 @default.
• W2064152041 cites W2012940838 @default.
• W2064152041 cites W2024354123 @default.
• W2064152041 cites W2036749000 @default.
• W2064152041 cites W2045048432 @default.
• W2064152041 cites W2055553511 @default.
• W2064152041 cites W2055981604 @default.
• W2064152041 cites W2062117877 @default.
• W2064152041 cites W2066398683 @default.
• W2064152041 cites W2072845025 @default.
• W2064152041 cites W2084332691 @default.
• W2064152041 cites W2085290177 @default.
• W2064152041 cites W2089887386 @default.
• W2064152041 cites W2095083502 @default.
• W2064152041 cites W2108275913 @default.
• W2064152041 cites W2123069998 @default.
• W2064152041 cites W2126021331 @default.
• W2064152041 cites W2129128251 @default.
• W2064152041 cites W2138313532 @default.
• W2064152041 cites W2155616447 @default.
• W2064152041 cites W2159138058 @default.
• W2064152041 cites W2163502830 @default.
• W2064152041 cites W2164885965 @default.
• W2064152041 cites W2379365975 @default.
• W2064152041 cites W2469377734 @default.
• W2064152041 cites W2618073389 @default.
• W2064152041 cites W4240754354 @default.
• W2064152041 doi "https://doi.org/10.3324/haematol.2015.123588" @default.
• W2064152041 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4486232" @default.
• W2064152041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25840599" @default.
• W2064152041 hasPublicationYear "2015" @default.
• W2064152041 type Work @default.
• W2064152041 sameAs 2064152041 @default.
• W2064152041 citedByCount "17" @default.
• W2064152041 countsByYear W20641520412016 @default.
• W2064152041 countsByYear W20641520412017 @default.
• W2064152041 countsByYear W20641520412018 @default.
• W2064152041 countsByYear W20641520412020 @default.
• W2064152041 countsByYear W20641520412021 @default.
• W2064152041 countsByYear W20641520412022 @default.
• W2064152041 crossrefType "journal-article" @default.
• W2064152041 hasAuthorship W2064152041A5000571638 @default.
• W2064152041 hasAuthorship W2064152041A5004386819 @default.
• W2064152041 hasAuthorship W2064152041A5008162182 @default.
• W2064152041 hasAuthorship W2064152041A5009314752 @default.
• W2064152041 hasAuthorship W2064152041A5012866839 @default.
• W2064152041 hasAuthorship W2064152041A5017327825 @default.
• W2064152041 hasAuthorship W2064152041A5021394406 @default.
• W2064152041 hasAuthorship W2064152041A5035905546 @default.
• W2064152041 hasAuthorship W2064152041A5037882458 @default.
• W2064152041 hasAuthorship W2064152041A5045667573 @default.
• W2064152041 hasAuthorship W2064152041A5060783496 @default.
• W2064152041 hasAuthorship W2064152041A5062691289 @default.
• W2064152041 hasAuthorship W2064152041A5068862906 @default.
• W2064152041 hasAuthorship W2064152041A5083349008 @default.
• W2064152041 hasAuthorship W2064152041A5083687455 @default.
• W2064152041 hasAuthorship W2064152041A5087799564 @default.
• W2064152041 hasBestOaLocation W20641520411 @default.
• W2064152041 hasConcept C126322002 @default.

• next